Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 6, 2010, Pages

  Anderson, R L ^a   Ternes, B ^a   Strand, K A ^a   Rowling, M J ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Kidney

Indexed keywords

ALBUMIN; CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; CREATININE; CUBILIN; CYTOCHROME P450 27B1; CYTOCHROME P450 ISOENZYME; MEGALIN; PARATHYROID HORMONE; PROTEIN DISABLED 2; RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOCYTOSIS; GENE EXPRESSION; HOMEOSTASIS; KIDNEY TUBULE ABSORPTION; LEAN BODY WEIGHT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; URINARY EXCRETION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; ZUCKER DIABETIC FATTY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CALCIFEDIOL; CALCIUM; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY; LDL-RECEPTOR RELATED PROTEIN 2; MALE; PARATHYROID HORMONE; RATS; RATS, ZUCKER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; VITAMIN D;

EID: 78649645213     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00218.2010     Document Type: Article

References (37)

1. Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57: 183-191, 2008.
2. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxy vitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 74: 1966-1971, 1984.
3. Carlin AM, Yager KM, Rao DS. Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass. Am J Surg 195: 349-352; discussion 352, 2008.
4. Cichewicz RH, Zhang Y, Seeram NP, Nair MG. Inhibition of human tumor cell proliferation by novel anthraquinones from daylilies. Life Sci 74: 1791-1799, 2004. (Pubitemid 38117105)
5. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 60: 2304-2312, 2000.
6. Garland CF, Grant WB, Mohr SB, Gorham ED, Garland FC. What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 65: S91-S95, 2007.
7. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24: 503-510, 2004.
8. Hong CY, Chia KS, Ling SL. Urinary protein excretion in Type 2 diabetes with complications. J Diabetes Complications 14: 259-265, 2000.
9. Iseki K, Tatsuta M, Uehara H, Iishi H, Yano H, Sakai N, Ishiguro S. Inhibition of angiogenesis as a mechanism for inhibition by 1alpha- hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 81: 730-733, 1999.
10. Kawaura A, Takahashi A, Tanida N, Oda M, Sawada K, Sawada Y, Maekawa S, Shimoyama T. 1 Alpha-hydroxyvitamin D3 suppresses colonic tumorigenesis induced by repetitive intrarectal injection of N-methyl- N-nitrosourea in rats. Cancer Lett 55: 149-152, 1990.
11. Kim MK, Il Kang M, Won Oh K, Kwon HS, Lee JH, Lee WC, Yoon KH, Son HY. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 73: 330-338, 2010.
12. Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr 137: 2576S-2579S, 2007.
13. Kong J, Qiao G, Zhang Z, Liu SQ, Li YC. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney Int 74: 1577-1581, 2008.
14. Kuoppala T. Alterations in vitamin D metabolites and minerals in diabetic pregnancy. Gynecol Obstet Invest 25: 99-105, 1988.
15. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007.
16. Mokady E, Schwartz B, Shany S, Lamprecht SA. A protective role of dietary vitamin D3 in rat colon carcinogenesis. Nutr Cancer 38: 65-73, 2000.
17. Morris SM, Tallquist MD, Rock CO, Cooper JA. Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. EMBO J 21: 1555-1564, 2002.
18. Nagai J, Christensen EI, Morris SM, Willnow TE, Cooper JA, Nielsen R. Mutually dependent localization of megalin and Dab2 in the renal proximal tubule. Am J Physiol Renal Physiol 289: F569-F576, 2005.
19. Nashold FE, Miller DJ, Hayes CE. 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 103: 171-179, 2000.
20. Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, Shinozaki H. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 22: 1871-1875, 2001.
21. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen E, Willnow T. An endocytic pathway essential for renal uptake and activation of the steroid 25(OH)hydroxyvitamin D3. Cell 96: 507-515, 1999. (Pubitemid 29106838)
22. Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, Verroust PJ, Aminoff M, de la Chapelle A, Moestrup SK, Ray R, Gliemann J, Willnow TE, Christensen EI. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA 98: 13895-13900, 2001.
23. Nyomba BL, Bouillon R, Lissens W, Van Baelen H, De Moor P. 1,25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats. Endocrinology 116: 2483-2488, 1985.
24. Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Muñoz A. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154: 369-387, 2001.
25. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 9: 187-190, 1988.
26. Risio M, Lipkin M, Newmark H, Yang K, Rossini FP, Steele VE, Boone CW, Kelloff GJ. Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res 56: 4910-4916, 1996.
27. Rodland O, Markestad T, Aksnes L, Aarskog D. Plasma concentrations of vitamin D metabolites during puberty of diabetic children. Diabetologia 28: 663-666, 1985.
28. Rowling MJ, Gliniak C, Welsh J, Fleet JC. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr 137: 2608-2615, 2007.
29. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813-2818, 2004.
30. Thrailkill KM, Nimmo T, Bunn RC, Cockrell GE, Moreau CS, Mackintosh S, Edmondson RD, Fowlkes JL. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multi-ligand receptors megalin and cubilin. Diabetes Care 32: 1266-1268, 2009.
31. Tojo A, Onozato ML, Ha H, Kurihara H, Sakai T, Goto A, Fujita T, Endou H. Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats. Histochem Cell Biol 116: 269-276, 2001.
32. van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 42: 260-266, 2008.
33. Verhaeghe J, Suiker AM, Van Bree R, Van Herck E, Jans I, Visser WJ, Thomasset M, Allewaert K, Bouillon R. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats. Am J Physiol Endocrinol Metab 265: E215-E223, 1993.
34. Vora JP, Zimsen SM, Houghton DC, Anderson S. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J Am Soc Nephrol 7: 113-117, 1996. (Pubitemid 26067097)
35. Wang Y, Zhou J, Minto AW, Hack BK, Alexander JJ, Haas M, Li YC, Heilig CW, Quigg RJ. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int 70: 882-891, 2006.
36. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC. Cardiac hypertrophy in vitamin D receptor knock-out mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288: E125-E132, 2005.
37. Xu WL, Liu JR, Liu HK, Qi GY, Sun XR, Sun WG, Chen BQ. Inhibition of proliferation and induction of apoptosis by gammatocotrienol in human colon carcinoma HT-29 cells. Nutrition 25: 555-566, 2009.